newsfilter
← Latest News
ACCESS Newswire·

Noble Capital Markets Initiates Equity Research Coverage on Cosmos Health with Outperform Rating and $1.40 Price Target

Rating and price target: Outperform rating with a $1.40 price targetImplied upside: approximately 493% above the $0.236 closing price on Tuesday, October 27, 2026Valuation basis: 1.42 times Noble's 2027 revenue